Skip to main content
. Author manuscript; available in PMC: 2022 Feb 7.
Published in final edited form as: Vaccine. 2019 Jul 11;37(35):5111–5120. doi: 10.1016/j.vaccine.2019.05.089

Table 1.

Groups of persons at increased risk of hepatitis B virus (HBV) infection targeted by hepatitis B vaccination pilot program.1

  1. Persons with behaviors that increase their risk of HBV infection
    1. Persons at risk of infection by sexual exposure:
      1. Sex partners of HBV-positive persons
      2. Sexually active persons who are not in a long-term, mutually monogamous relationship (e.g., persons with more than one sex partner during the previous six months)
      3. Men who have sex with men (MSM)
    2. Persons at risk for infection by percutaneous or mucosal exposure to blood:
      1. Current or recent injection drug users (IDU)
      2. Household contacts of HBV-positive persons
    3. Others:
      1. Persons with chronic liver disease
      2. Persons with HIV infection
      3. Persons from endemic countries (i.e., those with ≥ 2% prevalence of hepatitis B.
  2. Persons who receive care in a setting where a higher proportion of patients are at increased risk of HBV infection (I.e. universal settings)
    1. Sexually transmitted disease treatment facilities
    2. HIV testing or treatment facilities
    3. Facilities providing drug-abuse treatment and prevention services
    4. Health care settings targeting services to IDU
    5. Correctional facilities
    6. Health care settings targeting services to MSM
1

The pilot project did not include targeting hepatitis B vaccination of healthcare personnel, persons with end-stage renal disease, or international travelers to regions with high or intermediate levels of endemic HBV infection. Some awardees reported using some vaccine for non-pilot program targeted settings and patients such as at college events, persons with diabetes seen for care in FQHCs, and community outreach events targeting homless, minority, and immigant populations.